METAGENOMI THERAPEUTICS INC

$MGX
Institutional coverage

45 13F filers hold $MGX.

13F holders
45
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

3 holders · Q1 2026

$MGX is held by 3 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.05% to 0.05%, with an average of 0.05% of portfolio. Largest holder: Resolute Advisors LLC at 0.05%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 45 · Source: 13F-HR
01
Eads & Heald Wealth Management
787,900 sh
02
Marshall & Sullivan Inc.
764,306 sh
03
Forest Avenue Capital Management LP
0.15% of portfolio
528,993 sh
04
SMART Wealth LLC
0.56% of portfolio
516,761 sh
05
Leuthold Group, LLC
496,767 sh
06
Atlantic Edge Private Wealth Management, LLC
465,810 sh
07
Bonness Enterprises Inc.
0.01% of portfolio
395,800 sh
08
Swiss National Bank
2.38% of portfolio
264,391 sh
09
Mesirow Financial Investment Management, Inc.
201,300 sh
10
Evergreen Capital Management LLC
170,104 sh
See all 45 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $MGX in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $MGX in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 14:57 UTC.